HNRNPA2B1 and non-small cell lung carcinoma: In the present study, we found that knockdown of HNRNPA2B1 impaired proliferation and metastasis of NSCLC cells in vitro and in vivo, whereas overexpression of HNRNPA2B1 reversed these effects.